Pay in 4 interest-free payments of $6.82 Learn more
)
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
The Tirzepatide Advantage Unlike single-target medications, tirzepatide activates both GLP-1 and GIP receptors, offering: Anti-inflammatory effects: Reduces inflammatory cytokines and shifts immune responses toward healing Metabolic benefits: Improves insulin sensitivity and glucose metabolism Tissue-level changes: Stimulates thermogenesis and reduces fibrosis Enhanced fat mobilization: May help mobilize stubborn lipedematous fat stores Clinical Evidence: Early Promise A recent case series treated five women with lipedema using exenatide (a GLP-1 agonist) for 3-6 months, showing: Reduced pain and tenderness in affected areas Decreased tissue thickness measured by ultrasound Improved symptoms even without significant weight loss Better tissue consistency and reduced inflammation Crucially, improvements occurred even in patients who didnt lose weight, suggesting direct effects on lipedematous tissue beyond weight management
FDA approved it in 2019 to increase pain-free light exposure in adults with erythropoietic protoporphyria
We provide both brand-name semaglutide (Ozempic, Wegovy) and compounded formulations including compounded semaglutide with L-Carnitine for patients who want added metabolic support or who may not be the best fit for brand-name options
Bone research benefits from the ability of GHK-Cu to stimulate BMP-2 (bone morphogenetic protein 2)
BPC-157 is studied for a potential role in reducing inflammation and supporting tissue protection, particularly in the digestive system
US$ 27.34
US$ 29.84
US$ 20.64
US$ 22.32
US$ 21.86
US$ 21.38
US$ 21.76
US$ 22.17
US$ 22.57
